Biotech · Private company · Malvern, PA, US
PleoPharma, Inc.
Track this companyFree. Adds PleoPharma, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials21 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- NabilonePhase 3 · Cannabis WithdrawalClinicalTrials.gov · fetched Nov 12, 2026
- PP-01Phase 3 · Cannabis WithdrawalClinicalTrials.gov · fetched Nov 12, 2026
- GabapentinPhase 2 · Cannabis WithdrawalClinicalTrials.gov · fetched Nov 12, 2026
- PP-01 High DosePhase 2 · Cannabis WithdrawalClinicalTrials.gov · fetched Nov 12, 2026
- PP-01 Low DosePhase 2 · Cannabis WithdrawalClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Efficacy of PP-01 in Mitigating Cannabis Withdrawal Symptoms in Adults With Cannabis Use DisorderPHASE3 · RECRUITING · started Jun 17, 2026ClinicalTrials.gov NCT07644052 · fetched Nov 12, 2026
- Effect of PP-01 on Cannabis Withdrawal SyndromePHASE2 · COMPLETED · started Oct 27, 2022ClinicalTrials.gov NCT05494437 · fetched Nov 12, 2026
NIH awards1
- Phase 3 Trial of PP-01 for Mitigation of Cannabis Withdrawal in CUDFiscal year 2026 · $2.2MNIH RePORTER 1U01DA066079-01 · fetched Nov 12, 2026